Host cell protein knock-out cells for production of therapeutic proteins
AssigneeNovo Nordisk Healthcare AG
InventorsThomas Dock Steenstrup, Peder Lisby Norby
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and means for making Vitamin K-dependent protein compositions which are devoid or substantially devoid of protein contaminants. In particular, methods and means useful for the reduction or elimination of protein contaminants also being Vitamin K-dependent proteins are described.
Claims1
A method for producing a composition comprising a Vitamin K-dependent protein of interest having a substantially lower amount of protein contaminant Protein S expressed endogenously by a Chinese Ovary Hamster (CHO) host cell in the absence of modification, said method comprising the steps of:
- a) producing said host cell expressing a Vitamin K-dependent protein of interest comprising the following steps in any order:
- 1) transfecting a cell with a polynucleotide construct encoding a Vitamin K-dependent protein of interest;
- and
- 2) modifying said cell to express a substantially lower amount of endogenous Protein S by any method selected from:
- i) disruption by gene knock-out of the gene encoding endogenous Protein S;
- ii) transfection with a siRNA polynucleotide construct targeting a mRNA encoding Protein S;
- iii) transfection with a transcription factor being a Zinc finger protein binding to a DNA element of the gene encoding endogenous Protein S;
- iv) random mutagenesis for disruption of the gene encoding endogenous Protein S;
- and
- b) growing said host cell in a growth medium and harvesting said growth medium comprising said Vitamin K-dependent protein of interest;
- wherein said Vitamin K-dependent protein of interest is selected from the group consisting of:
- Protein S, GAS-6, Factor II (Prothrombin), Factor X, Factor IX, Protein C, Factor VII, Protein Z, Transmembrane gamma-carboxyglutamic acid protein 1, Transmembrane gamma-carboxyglutamic acid protein 2, Transmembrane gamma carboxyglutamic acid protein 3, Transmembrane gamma-carboxyglutamic acid protein 4, Bone Gla protein, Matrix Gla protein, and Osteocalcin.
Dependencies are inferred from the claim text.